Managing Myeloma
- 2011-10-13 - Patient Education: Multiple Myeloma - New Treatments Bring Hope for a Cure -- UCSF Medical Center
- 2011-10-13 - Phase 1 / 2 Clinical Trial Results of KRX-0401 (Perifosine) Plus Bortezomib and Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma Published in the Journal of Clinical Oncology -- PharmaLive
- 2011-10-11 - Nurse Practitioners' attitudes about cancer clinical trials and willingness to recommend research participation -- Contemp Clin Trials
- 2011-10-11 - Drs. Stadtmauer & Giralt discuss challenges managing the newly diagnosed multiple myeloma patient -- On line PR Media
- 2011-10-04 - Leukemia & Lymphoma Society of Canada illuminates blood cancer at Light the Night walk -- Straight.com
- 2011-10-04 - Onyx Seeks Myeloma Drug Approval -- Daily Markets
- 2011-10-03 - Brookline woman honored by Multiple Myeloma Research Foundation -- Telegraph Neighbors
- 2011-10-03 - Romidepsin-Bortezomib-Dexamethasone Combination May Be Effective In Relapsed/Refractory Myeloma -- The Myeloma Beacon
- 2011-09-30 - Millennium Joins MMRF in Multiple Myeloma Personalized Medicine Initiative -- Genetic Engineering & Biotechnology News
- 2011-09-19 - ManagingMyeloma.com announces new continuing education program for multiple myeloma
- 2011-09-07 - Pat’s Place: Battling My Health Insurance Company To Pay For My Myeloma Treatment -- The Myeloma Beacon
- 2011-09-07 - Lesions of Multiple Myeloma Adjacent to the Skull Are Better Visualized on F-18 Fluoroethyldimethyl-2-Hydroxyethylammonium (FECH) PET Images Than on F-18 FDG PET Images -- Clin Nuc Med
- 2011-08-30 - NCCN Guidelines for Multiple Myeloma Version 1.2012 are now Available; LBD induction therapy now Category 2A recommendation and bortezomib added to preferred maintenance regimens -- Managing Myeloma
- 2011-08-20 - Lenalidomide Maintenance Therapy After Donor Stem Cell Transplantation Is Not Recommended For Multiple Myeloma Patients -- The Myeloma Beacon
- 2011-08-12 - Gene Therapy Advance In Leukemia Suggests New Treatment Options For Multiple Myeloma -- The Myeloma Beacon